Saturday 14 Dec

Stock Market

Alexandria Pharma sales soar to EGP 1.7 billion by June 2024


Alexandria Pharma sales soar to EGP 1.7 billion by June 2024

The adjusted financial indicators of Alexandria Pharmaceutical and Chemical Industries Company showed that the company's profits increased by 71.3% on an annual basis during the last fiscal year.

In a statement, the company explained that it achieved profits amounting to 216.68 million Egyptian pounds during the fiscal year from July 2023 to the end of June 2024, compared to profits of 126.42 million Egyptian pounds in the previous fiscal year.

The company's sales also increased during the last fiscal year to 1.78 billion Egyptian pounds, compared to sales of 1.48 billion Egyptian pounds in the previous fiscal year.

Alexandria Pharmaceutical and Chemical Industries reported a net profit of 206.16 million Egyptian pounds from the beginning of July to the end of May 2024, compared to 120.87 million Egyptian pounds in profit during the same period of the previous fiscal year.

The company's revenue also increased during this period to 1.73 billion Egyptian pounds by the end of May, compared to 1.41 billion Egyptian pounds during the same period last year.